Table 3.
Impact of patients’ risk profile according to HFR score on outcomes within 30 days after TAVI
| Outcome | Impact of HFR score (per 1-point increase) |
|---|---|
| Adjusted OR (95%-CI) | |
| Mortality | 1.06 (1.05–1.07) |
| Myocardial infarction | 1.04 (1.02–1.06) |
| Stroke or TIA | 1.11 (1.10–1.12) |
| Bleeding1 | 1.08 (1.07–1.09) |
| Access-related vascular complication1 | 1.04 (1.02–1.05) |
| Permanent device implantation | 1.03 (1.02–1.04) |
| Acute renal failure with need for dialysis | 1.11 (1.09–1.12) |
Models were adjusted for patient age and gender
TIA transient ischemic attack, CI confidence interval; all other abbreviations as in Table 1
1Within 7 days, all other adverse events within 30 days